MIRAMISTIN
UNII QL5J8F55LH

Substance Identification & Data

This profile provides standardized clinical and technical data for Miramistin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QL5J8F55LH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 15809-19-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QL5J8F55LH

CAS Registry Number

15809-19-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MIRAMISTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C26H47N2O.Cl

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JQQZCIIDNVIQKO-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

72949

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[Cl-].C([N+](CCCNC(CCCCCCCCCCCCC)=O)(C)C)c1ccccc1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Miramistin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.